Graham Capital Management »

Corvus Pharmaceuticals shares owned by Graham Capital Management

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $215k 68k 3.18
2024-12-31 $98k 18k 5.35

More positions owned by Graham Capital Management

Strategy Cl A New (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Fidelity Wise Origin Bitcoin SHS Put Option (FBTC)
Eos Energy Enterprises Com Cl A Put Option (EOSE)
Purecycle Technologies Note 7.250% 8/1 (Principal)
Vaneck Etf Trust Gold Miners Etf (GDX)
Tilray Brands Note 5.200% 6/1 (Principal)
Sunrun Note 4.000% 3/0 (Principal)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Rivian Automotive Note 3.625%10/1 (Principal)

View all positions for Graham Capital Management

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
Point72 Asset Management
BlackRock
Vanguard Group
Adams Street Partners
Rtw Investments
Vivo Capital
Foresite Capital Management VI
Geode Capital Management
Perceptive Advisors
State Street Corporation
Morgan Stanley
Northern Trust
Goldman Sachs Group
Sphera Funds Management

View all funds holding Corvus Pharmaceuticals